Algert Global LLC Lowers Stock Holdings in Schrödinger, Inc. (NASDAQ:SDGR)

Algert Global LLC lowered its holdings in Schrödinger, Inc. (NASDAQ:SDGR - Free Report) by 27.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 91,890 shares of the company's stock after selling 34,870 shares during the period. Algert Global LLC owned about 0.13% of Schrödinger worth $1,773,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Barclays PLC raised its holdings in shares of Schrödinger by 421.6% in the 3rd quarter. Barclays PLC now owns 107,554 shares of the company's stock valued at $1,995,000 after acquiring an additional 86,933 shares in the last quarter. JPMorgan Chase & Co. grew its position in shares of Schrödinger by 3.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 122,702 shares of the company's stock worth $2,276,000 after buying an additional 4,403 shares during the last quarter. GAMMA Investing LLC grew its position in shares of Schrödinger by 87.5% in the 4th quarter. GAMMA Investing LLC now owns 2,796 shares of the company's stock worth $54,000 after buying an additional 1,305 shares during the last quarter. Avanza Fonder AB bought a new stake in shares of Schrödinger during the fourth quarter valued at approximately $577,000. Finally, Geneos Wealth Management Inc. boosted its position in shares of Schrödinger by 15.4% during the fourth quarter. Geneos Wealth Management Inc. now owns 59,996 shares of the company's stock valued at $1,157,000 after purchasing an additional 8,021 shares in the last quarter. Institutional investors own 79.05% of the company's stock.

Insider Activity at Schrödinger

In other news, insider Karen Akinsanya sold 16,723 shares of the company's stock in a transaction on Monday, April 14th. The stock was sold at an average price of $25.09, for a total transaction of $419,580.07. Following the sale, the insider now owns 15,625 shares of the company's stock, valued at approximately $392,031.25. This represents a 51.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Geoffrey Craig Porges sold 5,491 shares of the company's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $21.76, for a total value of $119,484.16. Following the sale, the chief financial officer now directly owns 27,544 shares in the company, valued at $599,357.44. This represents a 16.62% decrease in their position. The disclosure for this sale can be found here. 8.60% of the stock is currently owned by insiders.

Schrödinger Trading Down 1.7%

Shares of NASDAQ SDGR traded down $0.41 during trading on Tuesday, reaching $23.76. 713,906 shares of the company traded hands, compared to its average volume of 842,287. Schrödinger, Inc. has a 12-month low of $16.60 and a 12-month high of $28.47. The firm's fifty day simple moving average is $22.67 and its 200 day simple moving average is $21.86. The stock has a market cap of $1.74 billion, a P/E ratio of -10.15 and a beta of 1.84.

Schrödinger (NASDAQ:SDGR - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported ($0.82) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.81) by ($0.01). The firm had revenue of $59.55 million during the quarter, compared to analyst estimates of $54.60 million. Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. The company's quarterly revenue was up 62.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.86) earnings per share. As a group, research analysts expect that Schrödinger, Inc. will post -2.37 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. Piper Sandler lowered their price objective on Schrödinger from $50.00 to $45.00 and set an "overweight" rating for the company in a research note on Thursday, February 27th. KeyCorp upped their price objective on Schrödinger from $30.00 to $32.00 and gave the company an "overweight" rating in a research report on Wednesday, April 16th. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Buy" and an average price target of $32.80.

Schrödinger Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.